Insider Trading Alert - CHMT, HCCI And ICCC Traded By Insiders

Yesterday, March 22, 2016, 62 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $393.86 to $985,495,661.49.

Highlighted Stocks Traded by Insiders:

Chemtura (CHMT) - FREE Research Report

Orton Laurence Michael, who is VP, Corporate Controller at Chemtura, sold 2,000 shares at $27.00 on March 22, 2016. Following this transaction, the VP, Corporate Controller owned 16,161 shares meaning that the stake was reduced by 11.01% with the 2,000-share transaction.

The shares most recently traded at $25.88, down $1.12, or 4.33% since the insider transaction. Historical insider transactions for Chemtura go as follows:

  • 4-Week # shares sold: 3,993
  • 12-Week # shares sold: 4,861
  • 24-Week # shares sold: 10,986

The average volume for Chemtura has been 501,900 shares per day over the past 30 days. Chemtura has a market cap of $1.7 billion and is part of the basic materials sector and chemicals industry. Shares are down 3.96% year-to-date as of the close of trading on Tuesday.

Chemtura Corporation, together with its subsidiaries, develops, manufactures, and markets performance-driven engineered industrial specialty chemicals for industrial manufacturing customers in the United States and internationally. The company has a P/E ratio of 13.4. Currently, there are 5 analysts who rate Chemtura a buy, no analysts rate it a sell, and 4 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on CHMT - FREE

TheStreet Quant Ratings rates Chemtura as a hold. The company's strengths can be seen in multiple areas, such as its largely solid financial position with reasonable debt levels by most measures, attractive valuation levels and good cash flow from operations. However, as a counter to these strengths, we also find weaknesses including feeble growth in the company's earnings per share, deteriorating net income and disappointing return on equity. Get the full Chemtura Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Heritage-Crystal Clean (HCCI) - FREE Research Report

Schalliol Charles E, who is Director at Heritage-Crystal Clean, bought 1,000 shares at $8.60 on March 22, 2016. Following this transaction, the Director owned 38,536 shares meaning that the stake was boosted by 2.66% with the 1,000-share transaction.

The shares most recently traded at $9.05, up $0.45, or 4.97% since the insider transaction. Historical insider transactions for Heritage-Crystal Clean go as follows:

  • 4-Week # shares bought: 10,000
  • 4-Week # shares sold: 1,404
  • 12-Week # shares bought: 10,000
  • 12-Week # shares sold: 1,404
  • 24-Week # shares bought: 10,000
  • 24-Week # shares sold: 1,404

The average volume for Heritage-Crystal Clean has been 41,400 shares per day over the past 30 days. Heritage-Crystal Clean has a market cap of $206.0 million and is part of the industrial goods sector and industrial industry. Shares are down 13.21% year-to-date as of the close of trading on Tuesday.

Heritage-Crystal Clean, Inc., through its subsidiary, Heritage-Crystal Clean, LLC, provides parts cleaning, and hazardous and non-hazardous waste services to small and mid-sized customers in the manufacturing and vehicle maintenance sectors. The company has a P/E ratio of 152.5. Currently, there are 5 analysts who rate Heritage-Crystal Clean a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on HCCI - FREE

TheStreet Quant Ratings rates Heritage-Crystal Clean as a sell. The company's weaknesses can be seen in multiple areas, such as its generally disappointing historical performance in the stock itself and poor profit margins. Get the full Heritage-Crystal Clean Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

ImmuCell (ICCC) - FREE Research Report

Tomsche David Scott, who is Director at ImmuCell, bought 955 shares at $6.67 on March 22, 2016. Following this transaction, the Director owned 66,789 shares meaning that the stake was boosted by 1.45% with the 955-share transaction.

The shares most recently traded at $6.50, down $0.17, or 2.62% since the insider transaction. Historical insider transactions for ImmuCell go as follows:

  • 4-Week # shares bought: 175
  • 12-Week # shares bought: 175
  • 24-Week # shares bought: 175

The average volume for ImmuCell has been 13,000 shares per day over the past 30 days. ImmuCell has a market cap of $21.1 million and is part of the health care sector and drugs industry. Shares are down 13.4% year-to-date as of the close of trading on Monday.

ImmuCell Corporation develops, acquires, manufactures, and sells products that enhance animal health and productivity in the dairy and beef industries in the United States and internationally. The company has a P/E ratio of 20.2.

Exclusive Offer: Get the latest Stock Analysis on ICCC - FREE

TheStreet Quant Ratings rates ImmuCell as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, impressive record of earnings per share growth, compelling growth in net income, reasonable valuation levels and good cash flow from operations. Although no company is perfect, currently we do not see any significant weaknesses which are likely to detract from the generally positive outlook. Get the full ImmuCell Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

More from Markets

Stocks Waver Amid a Rise in Bond Yields, Strong Earnings

Stocks Waver Amid a Rise in Bond Yields, Strong Earnings

NYSE Suspends Trading for Some Shares of Amazon, Alphabet

NYSE Suspends Trading for Some Shares of Amazon, Alphabet

Video: Jim Cramer Reveals Why He's Cautious on Stocks

Video: Jim Cramer Reveals Why He's Cautious on Stocks

Jim Cramer on Earnings: All Stories Aren't Equal

Jim Cramer on Earnings: All Stories Aren't Equal

4 Stocks Making Important Moves Wednesday

4 Stocks Making Important Moves Wednesday